Federal Register / Vol. 86, No. 138 / Thursday, July 22, 2021 / Notices 38729 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; National Institute Of Allergy 

And Infectious Diseases (NIAID) Clinical Site 

Monitoring Center (CSMC). 

Date: August 17, 2021. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G53, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Konrad Krzewski, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G53, 

Rockville, MD 20852, 240–747–7526, 

konrad.krzewski@nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID 2021 DMID Omnibus 

BAA (HHS–NIH–NIAID–BAA2021–01) 

Research Area 002: Development of 

Therapeutic Products for Biodefense, AntiMicrobial Resistant (AMR) Infections and 

Emerging Infectious Diseases-Viral 

Therapeutics. 

Date: August 18–19, 2021. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G53, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Frank S. De Silva, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3G53, Rockville, MD 

20892–9823, (240) 669–5023, fdesilva@

niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: July 16, 2021. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–15557 Filed 7–21–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

contract proposals and the discussions 

could disclose confidential trade secrets 

or commercial property such as 

patentable material, and personal 

information concerning individuals 

associated with the grant applications 

and contract proposals, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Diagnosis 

and Treatment of Pediatric and Rare Cancers. 

Date: September 16–17, 2021. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W260, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Nadeem Khan, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W260, Rockville, Maryland 

20850, 240–276–5856, nadeem.khan@

nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; K22 

Transition Career Development Award. 

Date: September 21, 2021. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W234, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Adriana Stoica, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W234, Rockville, Maryland 20850, 

240–276–6368, Stoicaa2@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Program Project I (P01). 

Date: October 6–7, 2021. 

Time: 9:00 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W618, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Mukesh Kumar, Ph.D., 

Scientific Review Officer, Research Program 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W618, 

Rockville, Maryland 20850, 240–276–6611, 

mukesh.kumar3@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Program Project II. 

Date: October 12–13, 2021. 

Time: 9:30 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W116, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Klaus B. Piontek, Ph.D., 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W116, 

Rockville, Maryland 20850, 240–276–5413, 

klaus.piontek@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI SPORE 

(P50) Review I. 

Date: October 13–14, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W242, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: John Paul Cairns, Ph.D., 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W242, 

Rockville, Maryland 20850, 240–276–5415, 

paul.cairns@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI SPORE 

(P50) Review II. 

Date: October 14, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W248, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Anita T. Tandle, Ph.D., 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W248, 

Rockville, Maryland 20850, 240–276–5085, 

tandlea@mail.nih.gov. 


lotter on DSK11XQN23PROD with NOTICES1
38730 Federal Register / Vol. 86, No. 138 / Thursday, July 22, 2021 / Notices 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Program Project III. 

Date: October 20–21, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W648, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Michael E. Lindquist, 

Ph.D., Scientific Review Officer, Research 

Programs Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W648, Rockville, Maryland 20850 

mike.lindquist@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Technologies for Basic and Clinical Cancer 

Research. 

Date: October 28–29, 2021. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W260, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Nadeem Khan, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W260, Rockville, Maryland 

20850, 240–276–5856, nadeem.khan@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: July 16, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–15547 Filed 7–21–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

[Docket ID: FEMA- 2021–0013; OMB No. 

1660–0002] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request; Disaster 

Assistance Registration 

AGENCY: Federal Emergency 

Management Agency, Department of 

Homeland Security. 

ACTION: 30 Day notice of renewal and 

request for comments. 

SUMMARY: The Federal Emergency 

Management Agency (FEMA) will 

submit the information collection 

abstracted below to the Office of 

Management and Budget for review and 

clearance in accordance with the 

requirements of the Paperwork 

Reduction Act of 1995. The submission 

will describe the nature of the 

information collection, the categories of 

respondents, the estimated burden (i.e., 

the time, effort and resources used by 

respondents to respond) and cost, and 

the actual data collection instruments 

FEMA will use. 

DATES: Comments must be submitted on 

or before August 23, 2021. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: 

Requests for additional information or 

copies of the information collection 

should be made to Director, Information 

Management Division, email address 

FEMA-Information-CollectionsManagement@fema.dhs.gov or Brian 

Thompson, Supervisory Program 

Specialist, FEMA, Recovery Directorate, 

540–686–3602. 

SUPPLEMENTARY INFORMATION: This 

proposed information collection 

previously published in the Federal 

Register on April 12, 2021, at 86 FR 

19001 with a 60 day public comment 

period. No comments were received. 

The purpose of this notice is to notify 

the public that FEMA will submit the 

information collection abstracted below 

to the Office of Management and Budget 

for review and clearance. 

Collection of Information 

Title: Disaster Assistance Registration. 

Type of information collection: 

Extension, without change, of a 

currently approved information 

collection. 

OMB Number: 1660–0002. 

Form Titles and Numbers: FF–104– 

FY–21–123 (formerly FEMA Form 009– 

0–1T (English)), Tele-Registration, 

Disaster Assistance Registration; FF– 

104–FY–21–1123–A (formerly FEMA 

Form 009–0–1T (Spanish)), TeleRegistration, Registro Para Asistencia De 

Desatre; FF–104–FY–21–123–COVID– 

FA (formerly FEMA Form 009–0–1T– 

COVID–FA (English)), Tele-Registration, 

COVID–19 Funeral Assistance; FF–104– 

FY–21–125 (formerly FEMA Form 009– 

0–1Int (English)), Internet, Disaster 

Assistance Registration; FF–104–FY– 

21–125–A (formerly FEMA Form 009– 

0–2Int (Spanish)), Internet, Registro Para 

Asistencia De Desastre; FF–104–FY–21– 

122 (formerly FEMA Form 009–0–1 

(English)), Paper Application/Disaster 

Assistance Registration; FF–104–FY– 

21–122–A (formerly FEMA Form 009– 

0–2 (Spanish)), Solicitud en Papel/ 

Registro Para Asistencia De Desastre; 

FF–104–FY–21–128 (formerly FEMA 

Form 009–0–3 (English)), Declaration 

and Release; FF–104–FY–21–128–A 

(formerly FEMA Form 009–0–4 

(Spanish)), Declaracio ́n Y Autorizacio ́n; 

FF–104–FY–21–127 (formerly FEMA 

Form 009–0–5 (English)), Manufactured 

Housing Unit Revocable License and 

Receipt for Government Property; FF– 

104–FY–21–127–A (formerly FEMA 

Form 009–0–6 (Spanish)), Las Casas 

Manufacturadas Unidad Licencia 

Revocable y Recibo de la Propiedad del 

Gobierno; Request for Information (RFI). 

Abstract: The forms in this collection 

are used to obtain pertinent information 

to provide financial assistance, and if 

necessary, direct assistance to eligible 

individuals and households who, as a 

direct result of a disaster or emergency, 

have uninsured or under-insured, 

necessary or serious expenses they are 

unable to meet. This extension, without 

change, will also support the continued 

ability to provide COVID–19 Funeral 

Assistance to individuals who 

responsible for a deceased individual’s 

funeral expenses. 

Affected Public: Individuals or 

Households. 

Estimated Number of Respondents: 

2,004,488. 

Estimated Number of Responses: 

2,004,488. 

Estimated Total Annual Burden 

Hours: 622,707. 

Estimated Total Annual Respondent 

Cost: $24,441,251. 

Estimated Respondents’ Operation 

and Maintenance Costs: $0. 

Estimated Respondents’ Capital and 

Start-Up Costs: $0. 

Estimated Total Annual Cost to the 

Federal Government: $203,187,715. 

Comments 

Comments may be submitted as 

indicated in the ADDRESS caption above. 

Comments are solicited to (a) evaluate 

whether the proposed data collection is 

necessary for the proper performance of 

the agency, including whether the 

information shall have practical utility; 

(b) evaluate the accuracy of the agency’s 

estimate of the burden of the proposed 


lotter on DSK11XQN23PROD with NOTICES1